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Tokyo, JapanFigure 1. Chest Computed Tomography Before PTPA
Arrow indicate a large thrombosis in the main tract. PTPA ¼
percutaneous transluminal pulmonary angioplasty (Online Video 1).A 76-year-old man had severe pulmonary artery
stenosis in the main tract of the right pulmonary
artery (Fig. 1, Online Video 1), suggesting central-
type chronic thromboembolic pulmonary hyper-
tension (CTEPH). Percutaneous transluminal
pulmonary angioplasty (PTPA) was strategized
because he was excluded from surgical pulmonary
endarterectomy due to his severe chronic obstruc-
tive pulmonary dysfunction and poor physical
condition.
The procedure was divided into 2 staged
sessions performed on different days so as to
prevent large-scale pulmonary edema due to acute
revascularization. During the ﬁrst session, the
right pulmonary artery was incompletely dilated
using a 2.5- to 6-mm monorail balloon catheter
(Figs. 2A and 2B). The ﬁrst PTPA session
was stopped in an insufﬁcient state of pulmonary
ﬂow (Fig. 2C). One week later, the mean pulmo-
nary arterial pressure (PAP) had decreased to
29 mm Hg just before the second session (baseline,
41 mm Hg). The main lesion was dilated further
using a 10-mm balloon catheter, and pulmonary
blood ﬂow was signiﬁcantly improved, with rapid
increases in ﬂow (Figs. 3A and 3B, Online Video 2).
No major complications, including reperfusion
pulmonary edema, occurred. There was no pulmo-
nary restenosis seen on 6-month follow-up (mean
PAP 23 mm Hg).
Patients with central-type CTEPH have been
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consequences in terms of morbidity and mortality
(1,2). However, we have demonstrated that staged
revascularization by PTPA is effective in the
treatment of central-type CTEPH and therefore
may be a therapeutic option for these patients.Reprint requests and correspondence: Drs. Toru Satoh
or Masaharu Kataoka, Division of Cardiology, Depart-
ment of Medicine, Kyorin University School of Medicine,
6-20-2, Shinkawa, Mitaka, Tokyo 181-8611, Japan.
E-mail: tsatoh@ks.kyorin-u.ac.jp; or m.kataoka09@gmail.
com.
Figure 2. Angiographies at the First Session
Angiographies before PTPA (A), during dilation of the target lesion by the small-size balloon catheter (B), and after the ﬁrst session of PTPA (C). Abbreviations as in Figure 1.
Figure 3. Angiographies at the Second Session
Angiographies during dilation by a larger balloon catheter (A) and after the second session of PTPA (B). Abbreviations as in Figure 1 (Online Video 2).
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APPENDIX
For accompanying videos, please see the online version of this paper.
